Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

BIT:ELES - Euronext Milan - IT0005373417 - Common Stock - Currency: EUR

1.585  -0.02 (-0.94%)

Fundamental Rating

5

Taking everything into account, ELES scores 5 out of 10 in our fundamental rating. ELES was compared to 52 industry peers in the Semiconductors & Semiconductor Equipment industry. ELES has an average financial health and profitability rating. ELES is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ELES was profitable.
ELES had a positive operating cash flow in the past year.
ELES had positive earnings in each of the past 5 years.
Of the past 5 years ELES 4 years had a positive operating cash flow.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

ELES has a worse Return On Assets (2.24%) than 76.92% of its industry peers.
ELES has a Return On Equity of 4.47%. This is in the lower half of the industry: ELES underperforms 73.08% of its industry peers.
With a Return On Invested Capital value of 6.98%, ELES perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
ELES had an Average Return On Invested Capital over the past 3 years of 4.69%. This is significantly below the industry average of 15.85%.
The 3 year average ROIC (4.69%) for ELES is below the current ROIC(6.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELES has a worse Profit Margin (3.48%) than 76.92% of its industry peers.
ELES's Profit Margin has declined in the last couple of years.
ELES's Operating Margin of 12.08% is on the low side compared to the rest of the industry. ELES is outperformed by 67.31% of its industry peers.
ELES's Operating Margin has improved in the last couple of years.
The Gross Margin of ELES (51.40%) is better than 76.92% of its industry peers.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELES is destroying value.
ELES has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ELES has been increased compared to 5 years ago.
Compared to 1 year ago, ELES has an improved debt to assets ratio.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.18 indicates that ELES is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.18, ELES is doing worse than 76.92% of the companies in the same industry.
ELES has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as ELES would need 2.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.75, ELES is in line with its industry, outperforming 59.62% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.34, ELES is in line with its industry, outperforming 40.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.18
ROIC/WACC0.69
WACC10.11%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

ELES has a Current Ratio of 2.33. This indicates that ELES is financially healthy and has no problem in meeting its short term obligations.
ELES has a Current ratio (2.33) which is in line with its industry peers.
A Quick Ratio of 1.79 indicates that ELES should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.79, ELES is in line with its industry, outperforming 48.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.37% over the past year.
The Earnings Per Share has been growing slightly by 0.68% on average over the past years.
ELES shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.92%.
Measured over the past years, ELES shows a quite strong growth in Revenue. The Revenue has been growing by 15.31% on average per year.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

The Earnings Per Share is expected to grow by 41.50% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELES will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.05 0.1 0.15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.81, the valuation of ELES can be described as rather expensive.
ELES's Price/Earnings is on the same level as the industry average.
ELES's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.10.
A Price/Forward Earnings ratio of 15.54 indicates a correct valuation of ELES.
61.54% of the companies in the same industry are more expensive than ELES, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.74. ELES is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.81
Fwd PE 15.54
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

90.38% of the companies in the same industry are more expensive than ELES, based on the Enterprise Value to EBITDA ratio.
ELES's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ELES is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.57
EV/EBITDA 4.25
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELES's earnings are expected to grow with 41.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)29.01
EPS Next 2Y52.75%
EPS Next 3Y41.5%

More info and screens

0

5. Dividend

5.1 Amount

ELES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (5/2/2025, 7:00:00 PM)

1.585

-0.02 (-0.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.46%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap27.01M
Analysts82.86
Price Target3.18 (100.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.81
Fwd PE 15.54
P/S 0.76
P/FCF 4.57
P/OCF 4.29
P/B 0.97
P/tB 1.5
EV/EBITDA 4.25
EPS(TTM)0.08
EY5.05%
EPS(NY)0.1
Fwd EY6.44%
FCF(TTM)0.35
FCFY21.87%
OCF(TTM)0.37
OCFY23.3%
SpS2.1
BVpS1.63
TBVpS1.06
PEG (NY)0.3
PEG (5Y)29.01
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.18
F-Score9
WACC10.11%
ROIC/WACC0.69
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5YN/A
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5YN/A
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A